| Inhibitory effect of tumor cell–derived lactic acid on human T cells K Fischer, P Hoffmann, S Voelkl, N Meidenbauer, J Ammer, M Edinger, ... Blood 109 (9), 3812-3819, 2007 | 1834 | 2007 |
| Inhibitory effect of tumor cell–derived lactic acid on human T cells K Fischer, P Hoffmann, S Voelkl, N Meidenbauer, J Ammer, M Edinger, ... Blood 109 (9), 3812-3819, 2007 | 1834 | 2007 |
| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1715 | 2019 |
| A promoter-level mammalian expression atlas Nature 507 (7493), 462-470, 2014 | 1693 | 2014 |
| CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation M Edinger, P Hoffmann, J Ermann, K Drago, CG Fathman, S Strober, ... Nature medicine 9 (9), 1144-1150, 2003 | 1557 | 2003 |
| Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation P Hoffmann, J Ermann, M Edinger, CG Fathman, S Strober The Journal of experimental medicine 196 (3), 389-399, 2002 | 1395 | 2002 |
| DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells U Baron, S Floess, G Wieczorek, K Baumann, A Grützkau, J Dong, A Thiel, ... European journal of immunology 37 (9), 2378-2389, 2007 | 831 | 2007 |
| Large-scale in vitro expansion of polyclonal human CD4+ CD25high regulatory T cells P Hoffmann, R Eder, LA Kunz-Schughart, R Andreesen, M Edinger Blood 104 (3), 895-903, 2004 | 692 | 2004 |
| Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD J Ermann, P Hoffmann, M Edinger, S Dutt, FG Blankenberg, JP Higgins, ... Blood 105 (5), 2220-2226, 2005 | 535 | 2005 |
| Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and … E Holler, P Butzhammer, K Schmid, C Hundsrucker, J Koestler, K Peter, ... Biology of Blood and Marrow Transplantation 20 (5), 640-645, 2014 | 534 | 2014 |
| Only the CD45RA+ subpopulation of CD4+ CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion P Hoffmann, R Eder, TJ Boeld, K Doser, B Piseshka, R Andreesen, ... Blood 108 (13), 4260-4267, 2006 | 520 | 2006 |
| Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging M Edinger, YA Cao, MR Verneris, MH Bachmann, CH Contag, RS Negrin Blood, The Journal of the American Society of Hematology 101 (2), 640-648, 2003 | 430 | 2003 |
| Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation P Hoffmann, TJ Boeld, R Eder, J Huehn, S Floess, G Wieczorek, S Olek, ... European journal of immunology 39 (4), 1088-1097, 2009 | 412 | 2009 |
| A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma T Leemhuis, S Wells, C Scheffold, M Edinger, RS Negrin Biology of Blood and Marrow Transplantation 11 (3), 181-187, 2005 | 360 | 2005 |
| Noninvasive assessment of tumor cell proliferation in animal models M Edinger, TJ Sweeney, AA Tucker, AB Olomu, RS Negrin, CH Contag Neoplasia 1 (4), 303-310, 1999 | 328 | 1999 |
| Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials B Sawitzki, PN Harden, P Reinke, A Moreau, JA Hutchinson, DS Game, ... The Lancet 395 (10237), 1627-1639, 2020 | 314 | 2020 |
| Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants R Hehlmann, M Lauseker, S Saußele, M Pfirrmann, S Krause, HJ Kolb, ... Leukemia 31 (11), 2398-2406, 2017 | 312 | 2017 |
| Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity C Schmidl, M Klug, TJ Boeld, R Andreesen, P Hoffmann, M Edinger, ... Genome research 19 (7), 1165-1174, 2009 | 312 | 2009 |
| Advancing animal models of neoplasia through in vivo bioluminescence imaging M Edinger, YA Cao, YS Hornig, DE Jenkins, MR Verneris, MH Bachmann, ... European journal of cancer 38 (16), 2128-2136, 2002 | 291 | 2002 |
| FANTOM5 CAGE profiles of human and mouse samples S Noguchi, T Arakawa, S Fukuda, M Furuno, A Hasegawa, F Hori, ... Scientific data 4 (1), 1-10, 2017 | 231 | 2017 |
